CD36 and cancer: Moreover, recent studies have revealed that CD36 contributes to the tumorigenesis and development of multiple cancer types by reprogramming the metabolism of glucose and fatty acid44–46, providing new insights for developing potential therapeutic target and prognostic biomarker in the clinical setting.